Company Analysis

Century Therapeutics, Inc. (IPSC)

Nasdaq: IPSC · Biological Products, (No Diagnostic Substances) · Philadelphia, PA · filing with the SEC since 2021
Grade5.7
◀ Past 4.6● Present 6.2▶ Future 6.1
1 est.

Who runs Century Therapeutics, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Pfeiffenberger Brent
President and CEO. First filing Dec 2023, latest Sep 15, 2026, 8 filings in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
21 people on the record since 2021
Officerssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Carr DouglasSVP Finance & OperationsJun 2021Nov 5, 202611 · $0.00
Pfeiffenberger BrentPresident and CEODec 2023Sep 15, 20261 · $0.00
Russotti GregoryTitle: Chief Technology and Manufacturing OfficerJun 2021Sep 15, 20267 · $0.00
Cowan ChadChief Scientific OfficerOct 2024Jun 15, 20261 · $0.00
Directorssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameRoleFirst filingLatest filingSales, 12 months
Truitt JosephdirectorSep 2026Sep 10, 2026none
Blackwell KimberlydirectorJun 2021Jun 12, 2026none
Lee Han MyungdirectorDec 2025Jun 12, 2026none
Murphy Martin PatrickdirectorApr 2026Jun 12, 2026none
Quimi DaphnedirectorOct 2022Jun 12, 2026none
Riva AlessandrodirectorJun 2021Jun 12, 2026none
Earlier names on the record23, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton IPSC · research, not advice